Form D · Biotechnology
One Unlimited, Inc.
Tampa, FL · CIK 0001474594
Offering snapshot reported May 12, 2017 · SEC filing
- Reported sold
- $10K Offering amount: $400K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 2, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 12, 2017 | Initial | $10,000 | No comparison | 1 | SEC filing |
| Mar 20, 2014 | Amendment | $275,000 | No comparison | 13 | SEC filing |
| Mar 21, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 17, 2013 | Initial | $214,080 | No comparison | 8 | SEC filing |
| Jul 3, 2012 | Initial | $187,699 | No comparison | 6 | SEC filing |
| Apr 23, 2012 | Amendment | $111,043 | $85,000vs Jun 2, 2011 | 7 | SEC filing |
| Jun 2, 2011 | Initial | $26,043 | No comparison | 4 | SEC filing |
| Oct 15, 2009 | Initial | $414,080 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-286658
The total offering amount includes the 40 Units at $5000 each, and the assumed exercise at $.50 of all of the 400000 Warrants. The minimum offering amount is $80000.
Forty "Units" at $5000 each, with Unit consisting of 2500 shares of Common Stock and 10000 Warrants each exercisable at $.50 for one additional share of Common Stock
Source: Form D, filed May 12, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wilber D Allen | Director, Executive |
| Jennifer R Allen | Director, Executive |
| Keith Collins | Director |
| Jeffrey R. Edwards | Director |
| Robert E. Galloway | Executive |
| William C Leasure | Director, Executive |
| William C. Leasure Iv | Director |
| L. William Luria | Director, Executive |
| Nancy Mercurio | Director |
| Tanya Rhodes | Director |
| Joy Allen St John | Director |
| Scott M. Tappan | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4314 Middle Lake Drive
Tampa, FL, 33624
Tampa, FL, 33624